Victorian pharmacy researchers have successfully expanded their Australia-first collaborative medication charting model, showing partnership between pharmacists and clinicians at the leading edge of practice can reduce medication errors and improve patient care and safety, while improving the efficiency of the health system.
SHPA has welcomed the release of the Strengthening Medicare Taskforce Report, while reiterating that hospital-led expansion of pharmacists’ scope of practice is key to reforming and transforming Australia’s healthcare systems for greater sustainability and improved patient outcomes.
SHPA has welcomed yesterday’s announcement by the Federal Minister for Health and Aged Care, the Hon. Greg Hunt MP on the listing of molnupiravir (Lagevrio) on the Pharmaceutical Benefits Scheme (PBS).
2021 World Antimicrobial Awareness Week: Spread awareness, stop resistance: SHPA members are leading charge during 2021 World Antimicrobial Awareness Week (WAAW), highlighting best practices to help stop the further emergence and spread of antibiotic resistance as the COVID-19 pandemic continues.
Our evidence-based views on key topics and issues relevant to the professional role of members, key stakeholders, government and the community.
Our expert understanding of the multiple funding and regulatory frameworks with respect to medicines.
Advocating to ensure pharmacists in hospitals and other healthcare settings are appropriately utilised in this dynamic new healthcare landscape.
